REVIEW ■ : Neuroprotection in Brain Ischemia: An Update (Part I

Abstract

Ischemic brain injury produced by stroke or cardiac arrest is a major cause of human neurological disability. Steady advances in the neurosciences have elucidated pathophysiological mechanisms of brain ischemia and have suggested many therapeutic approaches directed at specific injury mechanisms to achieve neuroprotection of the acutely ischemic brain. The first portion of this two-part review highlights the differentiating features and pathological mechanisms of focal and global cerebral ischemic injury and summarizes a wealth of recent evidence as to how antagonism of excitatory amino acid neurotoxicity, mediated via NMDA as well as non-NMDA receptors, may offer a means of diminishing the extent of ischemic injury. The Neuroscientist 1:95-103, 1995

Keywords

KEY WORDS Stroke Cerebrovascular disease Neuroprotection

Get full access to this article

View all access options for this article.

References

Ginsberg MD Emerging strategies for the treatment of ischemic brain injury. In: Waxman SG , editor. Molecular and cellular approaches to the treatment of neurological disease. ARNMD Research Publication Series, vol 71. New York: Raven Press 1993;207-237.

Ginsberg MD , Busto R. Progress review: rodent models of cerebral ischemia. Stroke 1989;20:1627-1642.

Petito CK , Feldmann E. , Pulsmelli WA , Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 1987;37:1281-1286.

Heiss W-D. , Rosner G. Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol 1983;14:294-301.

Gmsberg MD The concept of the therapeutic window—a synthesis of critical issues . In: Moskowitz MA , editor. Proceedings of the nineteenth Pnnceton conference on cerebrovascular diseases . Stoneham, MA: Butterworth-Heinemann . 1994 (in press).

Strong AJ , Venables GS , Gibson G. The cortical ischaemic penumbra associated with occlusion of the middle cerebral artery in the cat: 1. Topography of changes in blood flow, potassium ion activity, and EEG. J Cereb Blood Flow Metab 1983;3:86-96.

Nedergaard M. , Astrup J. Infarct nm: effect of hyperglycemia on direct current potential and (14C)2-deoxyglucose phosphorylation . J Cereb Blood Flow Metab 1986;6:607-615.

Back T. , Kohno K. , Hossmann K-A. Cortical negative DC deflections following middle cerebral artery occlusion and KClinduced spreading depression: effect on blood flow, tissue oxygenation, and electroencephalogram. J Cereb Blood Flow Metab 1994;14:12-19.

Takeda Y. , Jacewicz M. , Takeda Y. , Nowak TS Jr, Pulsinelli WA DC-potential and energy metabolites in the focal ischemia. J Cereb Blood Flow Metab 1993;13[Suppl 1]:S450.

10.

Heiss W-D. , Graf R. , Wienhard K. , et al. Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 1994;14:892-902

11.

Gmsberg MD , Reivich M. , Giandomenico A. , Greenberg JH Local glucose utilization in acute focal cerebral ischemia: local dysmetabohsm and diaschisis. Neurology 1977 ;27:1042-1048.

12.

Shiraishi K. , Sharp FR , Simon RP Sequential metabolic changes in rat brain following middle cerebral artery occlusion: a 2-deoxyglucose study. J Cereb Blood Flow Metab 1989;9:765-773.

13.

Back T. , Gmsberg MD , Zhao W. , et al. Three-dimensional image analysis of local metabolism-blood flow uncoupling in photothrombotic MCA occlusion in rats. Soc Neurosci Abstr 1994; 20:1761.

14.

Busto R. , Gmsberg MD Graded focal cerebral ischemia in the rat by unilateral carotid artery occlusion and elevated intracramal pressure: hemodynamic and biochemical characterization . Stroke 1985;16:466-476.

15.

Kraig RP , Pulsinelh WA , Plum F. Hydrogen ion buffering during complete brain ischemia. Brain Res 1985;342:281-290

16.

Major ongoing stroke trials. Stroke 1994;25:541-545.

17.

Lipton SA , Rosenberg PA Excitatory amino acids as a final common pathway for neurologic disorders . N Engl J Med 1994;330:613-622.

18.

Lucas DR , Newhouse JP The toxic effect of sodium-L-glutamate on the inner layers of retina. Arch Ophthalmol 1957; 58:193-201.

19.

Olney JW Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 1969;164:719-721

20.

Rothman SM Synaptic activity mediates death of hypoxic neurons. Science 1983;220:536-537.

21.

Rothman S. Synaptic release of excitatory ammo acid neurotransmitter mediates anoxic neuronal death. J Neurosci 1984;4: 1884-1891.

22.

Pellegrini-Giampietro DE , Zukin RS , Bennett Mvl , Cho S. , Pulsinelli WA Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats . Proc Natl Acad Sci U S A 1992;89:10499-10503.

23.

Rothman SM , Olney JW Glutamate and the pathophysiology of hypoxic-ischemic brain damage . Ann Neurol 1986;19:105-111.

24.

Rothman SM Excitotoxins: possible mechanisms of action. Ann N Y Acad Sci 1992;648:132-139.

25.

Siesjo BK , Bengtsson F. Review. Calcium fluxes, calcium antagomsts, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis . J Cereb Blood Flow Metab 1989;9:127-140.

26.

Beckman JS , Beckman TW , Chen J. , Marshall PA , Freeman BA Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990;87:1620-1624.

27.

Benvemste H. The excitotoxm hypothesis in relation to cerebral ischemia. Cerebrovasc Brain Metab Rev 1991 ;3:213-245.

28.

Benvemste H. , Drejer J. , Schousboe A. , Diemer NH Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis . J Neurochem 1984;43:1369-1374.

29.

Globus My-T , Busto R. , Dietrich WD , Martinez E. , Valdes I. , Ginsberg MD Effect of ischemia on the in vivo release of stnatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J Neurochem 1988;51:1455-1464.

30.

Butcher SP , Bullock R. , Graham DI , McCulloch J. Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke 1990;21:1727-1733.

31.

Takagi K. , Gmsberg MD , Globus My-T , et al. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology. J Cereb Blood Flow Metab 1993;13:575-585.

32.

Globus My-T , Busto R. , Martinez E. , Valdes I. , Dietrich WD , Ginsberg MD Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. J Neurochem 1991;57:470-478.

33.

Globus My-T , Ginsberg MD , Busto R. Excitotoxic index—a biochemical marker of selective vulnerability. Neurosci Lett 1991;127:39-42.

34.

Simon RP , Swan JH , Gnffiths T. , Meldrum BS Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 1984;226:850-852.

35.

Swan JH , Evans MC , Meldrum BS Long-term development of selective neuronal loss and the mechanism of protection by 2-amino-7-phosphonoheptanoate in a rat model of incomplete forebrain ischemia . J Cereb Blood Flow Metab 1988;8:64-78.

36.

Buchan AM Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted? Cerebrovasc Brain Metab Rev 1990 ;2:1-26.

37.

Scatton B. , Carter C. , Benavides J. , Giroux C. N-methyl-D-aspartate receptor antagonists: a novel therapeutic perspective for the treatment of ischemic brain injury. Cerebrovasc Dis 1991; 1:121-135.

38.

Albers GW Review. Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia. Clin Neuropharmacol 1990 ;13:177-197.

39.

Wong Ehf , Kemp JA , Pnestley T. , Knight AR , Woodruff GN , Iversen LL The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist . Proc Natl Acad Sci U S A 1986; 83:7104-7108.

40.

Huettner JE , Bean BP Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci U S A 1988;85:1307-1311.

41.

Gill R. , Foster AC , Woodruff GN Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J Neurosci 1987;7:3343-3349.

42.

Gill R. , Foster AC , Woodruff GN MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period. Neuroscience 1988;25:847-855.

43.

Rod MR , Auer RN Pre- and post-ischemic administration of dizocilpine (MK-801) reduces cerebral necrosis in the rat. Can J Neurol Sci 1989 ; 16:340-344.

44.

Buchan A. , Pulsinelli WA Hypothermia but not the N-methyl-D-aspartate antagonist MK-801 attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci 1990;10:311-316.

45.

Corbett D. , Evans S. , Thomas C. , Wang D. , Jonas RA MK-801 reduces cerebral ischemic injury by inducing hypothermia. Brain Res 1990;514:300-304.

46.

Buchan A. , Li H. , Pulsinelli WA The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats . J Neurosci 1991;11:1049-1056.

47.

Gill R. , Woodruff GN The neuroprotective actions of kynuremc acid and MK-801 in gerbils are synergistic and not related to hypothermia. Eur J Pharmacol 1990;176:143-149.

48.

Von Lubitz Dkje , McKenzie RJ , Lin Rc-S , Devlin TM , Skolnick P. MK-801 is neuroprotective but does not improve survival in severe forebrain ischemia. Eur J Pharmacol 1993;233:95-100.

49.

Michenfelder JD , Lanier WL , Scheithauer BW , Perkins WJ , Shearman GT , Milde JH Evaluation of the glutamate antagonist dizocilipine maleate (MK-801 ) on neurologic outcome in a canine model of complete cerebral ischemia: correlation with hippocampal histopathology. Brain Res 1989;481:228-234.

50.

Lanier WL , Perkins WJ , Karlsson BR , Milde JH , Scheithauer BW , Shearman GT , Michenfelder JD The effects of dizocilpine maleate (MK-801), an antagonist of the N-methyl-D-aspartate receptor, on neurologic recovery and histopathology following complete cerebral ischemia in primates. J Cereb Blood Flow Metab 1990;10:252-261.

51.

Lin B. , Dietnch WD , Ginsberg MD , Globus My-T , Busto R. MK-801 (dizocilpine) protects the brain from repeated normothermic global ischemic insults in the rat. J Cereb Blood Flow Metab 1993;13:925-932.

52.

Dietrich WD , Busto R. , Alonso O. , Globus My-T , Gmsberg MD Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J Cereb Blood Flow Metab 1993;13:541-549.

53.

Lm B. , Dietnch WD , Busto R. , Kraydieh S. , Globus My-T , Ginsberg MD Postischemic brain hypothermia combined with delayed MK-801 treatment protects chronically after global ischemia in rats. Stroke 1994;28:254.

54.

Kochhar A. , Zivin JA , Lyden PD , Mazzarella V. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch Neurol 1988;45:148-153.

55.

Ozyurt E. , Graham DI , Woodruff GN , McCulloch J. Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat. J Cereb Blood Flow Metab 1988;8:138-143.

56.

Park CK , Nehls DG , Graham DI , Teasdale GM , McCulloch J. Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia. J Cereb Blood Flow Metab 1988;8:757-762.

57.

Park CK , Nehls DG , Graham DI , Teasdale GM , McCulloch J. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol 1988;24:543-551.

58.

Dirnagl U. , Tanabe J. , Pulsinelli W. Pre- and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the rat. Brain Res 1990;527:62-68.

59.

Gill R. , Brazell C. , Woodruff GN , Kemp JA The neuroprotective action of dizocilpine (MK-801 ) in the rat middle cerebral artery occlusion model of focal ischaemia. Br J Pharmacol 1991;103:2030-2036.

60.

Yang G. , Chan PH , Chen SF , Babuna OA , Simon RP , Weinstein PR Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia. Neurosurgery 1994 ;34:339-345.

61.

Buchan AM , Slivka A. , Xue D. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res 1992;574:171-177.

62.

Roussel S. , Pinard E. , Seylaz J. Effect of MK-801 on focal brain infarction in normotensive and hypertensive rats. Hypertension 1992;19:40-46.

63.

Yao H. , Markgraf CG , Dietrich WD , Prado R. , Watson BD , Ginsberg MD Glutamate antagonist MK-801 attenuates incomplete but not complete infarction in thrombotic distal middle cerebral artery occlusion in Wistar rats. Brain Res 1994;642:117-122.

64.

Dezsi L. , Greenberg JH , Sladky J. , Araki N. , Hamar J. , Reivich M. Prolonged effects of MK-801 in the cat during focal cerebral ischemia and recovery: Survival, EEG activity and histopathology. J Neurol Sci 1994;121:110-120.

65.

Novelh A. , Reilly JA , Lysko PG , Henneberry RC Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988;451:205-212.

66.

Iijima T. , Mies G. , Hossmann K-A. Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK-801: effect on volume of ischemic injury. J Cereb Blood Flow Metab 1992;12:727-733.

67.

Gill R. , Andine P. , Hillered L. , Persson L. , Hagberg H. The effect of MK-801 on cortical spreading depression in the penumbral zone following focal ischaemia in the rat. J Cereb Blood Flow Metab 1992;12:371-379.

68.

Mies G. , Kohno K. , Hossmann K-A. MK-801, a glutamate antagonist, lowers flow threshold for inhibition of protein synthesis after middle cerebral artery occlusion of rat. Neurosci Lett 1993;155:65-68.

69.

Gass P. , Herdegen T. , Bravo R. , Kiessling M. Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801. Neuroscience 1993;53:749-758.

70.

Sharp FR , Jasper P. , Hall J. , Noble L. , Sagar SM MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann Neurol 1991;30:801-809.

71.

Kurumaji A. , McCulloch J. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane . J Cereb Blood Flow Metab 1989;9:786-794.

72.

Dietrich WD , Ginsberg MD , Busto R. , Globus My-T. Influence of MK-801 on functional brain activation. In: Ginsberg MD, Dietrich WD , editors. Cerebrovascular diseases—sixteenth research (Princeton) conference. New York: Raven Press 1989;79-85.

73.

Olney JW , Labruyere J. , Pnce MT Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989;244:1360-1362.

74.

Fix AS , Horn JW , Wightman KA , et al: Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Exp Neurol 1993;123:204-215.

75.

Auer RN , Coulter KC The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801. Acta Neuropathol 1994;87:1-7.

76.

Franklin PH , Murray TF High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel . Mol Pharmacol 1992;41:134-146.

77.

Goldberg MP , Pham P-C. , Choi DW Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture. Neurosci Lett 1987;80:11-15.

78.

Stemberg GK , George CP , DeLaPaz R. , Shibata DK , Gross T. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits . Stroke 1988;19:1112-1118.

79.

Steinberg GK , Kums D. , DeLaPaz R. , Poljak A. Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favorable dose response profile . Neurol Res 1993;15:174-180.

80.

Paul KL The safety and tolerability of the glutamate antagonist Ro 01-6794 (dextrorphan HCl) in patients with acute ischemic stroke. In: Kneglstein J , Oberpichler-Schwenk H , editors. Pharmacology of cerebral ischemia 1994. Stuttgart: Wissentschaftliche Verlagsgesell 1994 (in press).

81.

Carter CJ , Lloyd KG , Zivkovic B. , Scatton B. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. J Pharmacol Exp Ther 1990 ; 253:475-482.

82.

Gotti B. , Duverger D. , Bertin J. , et al. Ifenprodil and SL-82.0715 as cerebral anti-ischemic agents. 1. Evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther 1988;247:1211-1221.

83.

Meadows M-E. , Fisher M. , Minematsu K. Delayed treatment with a noncompetitive NMDA antagonist, CNS-1102, reduces infarct size in rats. Cerebrovasc Dis 1994;4:26-31.

84.

Lehmann J. , Hutchison AJ , McPherson SE , et al. CGS-19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist. J Pharmacol Exp Ther 1988;246:65-75.

85.

Lehmann J. , Schneider J. , McPherson S. , et al. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist— characterization in vitro and in vivo. J Pharmacol Exp Ther 1987;240:737-746.

86.

Boast CA , Gerhardt SC , Pastor G. , Lehmann J. , Etienne PE , Liebman JM The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils. Brain Res 1988;442:345-348.

87.

Grotta JC , Picone CM , Ostrow PT , et al. CGS-19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia. Ann Neurol 1990;27:612-619.

88.

Simon R. , Shiraishi K. N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism . Ann Neurol 1990;27:606-611.

89.

Chen M. , Bullock R. , Graham DI , Frey P. , Lowe D. , McCulloch J. Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia. Ann Neurol 1991;30:62-70.

90.

Park CK , McCulloch J. , Kang JK , Choi CR Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat. Neurosci Lett 1992;147:41-44.

91.

Markabi S. CGS 19755. In: Kneglstein J , Oberpichler-Schwenk H , editors. Pharmacology of cerebral ischemia 1994. Stuttgart: Wissentschaftliche Verlagsgesell 1994 (in press).

92.

Kemp JA , Leeson PD The glycine site of the NMDA receptor— five years on. Trends Pharmacol Sci 1993;14:20-25.

93.

Wood ER , Bussey TJ , Phillips AG A glycine antagonist 7-chlorokynurenic acid attenuates ischemia-induced learning deficits. Neuroreport 1993;4:151-154.

94.

Von Lubitz Dkje , Lin Rc-S , McKenzie RJ , Devlin TM , McCabe RT , Skolnick P. A novel treatment of global cerebral ischaemia with a glycine partial agonist. Eur J Pharmacol 1992;219:153-158.

95.

Choi DW Excitotoxic cell death. J Neurobiol 1992;23:1261-1276.

96.

Kaku DA , Goldberg MP , Choi DW Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose. Brain Res 1991;554:344-347.

97.

Sheardown MJ , Nielsen EO , Hansen AJ , Jacobsen P. , Honore T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 1990;247:571-574.

98.

Buchan AM , Li H. , Cho S. , Pulsinelli WA Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci Lett 1991;132:255-258.

99.

Nellgard B. , Wieloch T. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J Cereb Blood Flow Metab 1992;12:2-11.

100.

Sheardown MJ , Suzdak PD , Nordholm L. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur J Pharmacol 1993;236:347-353.

101.

Li H. , Buchan AM Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J Cereb Blood Flow Metab 1993;13:933-939.

102.

Gill R. , Nordhom L. , Lodge D. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Brain Res 1992;580:35-43.

103.

Xue D. , Huang Z-G. , Barnes K. , Lesiuk HJ , Smith KE , Buchan AM Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J Cereb Blood Flow Metab 1994;14:251-261.

104.

Mies G. , Kohno K. , Hossmann K-A. Prevention of periinfarct direct current shifts with glutamate antagonist NBQX following occlusion of the middle cerebral artery in the rat . J Cereb Blood Flow Metab 1994 ;14:802-807.

105.

Le Peillet E. , Arvin B. , Moncada C. , Meldrum BS The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat. Brain Res 1992;571:115-120.

106.

Smith SE , Meldrum BS Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat. Stroke 1992 ;23:861-864.

107.

Schoepp DD , Conn PJ Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci 1993;14:13-20.

108.

Bortolotto ZA , Bashir ZI , Davies CH , Colhngridge GL A molecular switch activated by metabotropic glutamate receptors regulates induction of long-term potentiation. Nature 1994;368:740-743.

109.

McDonald JW , Fix AS , Tizzano JP , Schoepp DD Seizures and brain injury m neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist . J Neurosci 1993;13:4445-4455.

110.

Pizzi M. , Fallacara C. , Arrighi V. , Memo M. , Spano P. Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. J Neurochem 1993;61:683-689.

111.

Meldrum BS , Swan JH , Leach MJ , et al. Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87. Brain Res 1992;593:1-6.

112.

Lekieffre D. , Meldrum BS The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats. A microdialysis and histological study. Neuroscience 1993;56:93-99.

113.

Graham SH , Chen J. , Sharp FR , Simon RP Limiting ischemic injury by inhibition of excitatory ammo acid release . J Cereb Blood Flow Metab 1993;13:88-97.

114.

Smith SE , Lekieffre D. , Sowinski P. , Meldrum BS Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat. Neuroreport 1993;4:1339-1342.

115.

Leach MJ , Swan JH , Eisenthal D. , Dopson M. , Nobbs M. BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke 1993;24:1063-1067.